Skip to content

Role of the Spouse/Partner of Persons Treated With Chemotherapy for Colon Cancer

Role of the Spouse/Partner of Persons Treated With Chemotherapy for Colon Cancer - Preliminary Validation of the Caregiver Objective Burden-Quality of Life (COBQoL) Questionnaire

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02873845
Acronym
APPACH
Enrollment
12
Registered
2016-08-22
Start date
2014-05-31
Completion date
Unknown
Last updated
2016-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Brief summary

Altered quality of life in patients with stage III or IV colon cancer is well known. At their sides, their spouse/partner must also cope with the suffering caused by the disease and the upheavals that it engenders, with the treatments, in the organization of their everyday life. The physical, emotional, social and financial impact of cancer in general and its treatment on care-givers has already been studied. However, there are no data concerning the objective burden, that is to say the nature and the magnitude of the care weighing on the spouse of persons with colon cancer. Objective is to develop and validate a questionnaire that can be completed by the spouse/partner of patients with stage III or IV colon cancer so as to evaluate the burden of the disease in everyday life. It will allow medico-social professionals to identify spouses/partners in difficulty and the needs of patients so as to offer the best support.

Interventions

OTHERPreliminary validation of the COBQoL questionnaire

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria for patients: Men or women : * able to understand written and spoken French ; * Who have been informed about the study; * with stage III or IV cancer of the colon or recto-sigmoid junction (Code C18 and C19 of the ICD 10), operated or not with curative intent; treated with chemotherapy in one of the study centres (adjuvant or 1st-line chemotherapy or palliative chemotherapy); * Currently living with a spouse or partner; * Who has consented to his/her spouse/partner taking part in the study. Inclusion criteria for the spouse/partner: Men or women: * able to understand written and spoken French ; * Who have been informed about the study; living at the home of the spouse/partner; * Able to take part in an interview of approximately one hour; * Who has provided consent to take part in the study.

Design outcomes

Primary

MeasureTime frame
Objective burden score in the dimensions of the COBQoL questionnaire with good psychometric propertiesthrough study completion, an average of 1 year

Countries

France

Contacts

Primary ContactCatherine LEJEUNE
catherine.lejeune@u-bourgogne.fr03 80 39 34 88

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026